In late 2014, Congress passed the Sunscreen Innovation Act (SIA) to speed the approval of innovative new sunscreen ingredients and formulations, many of which have long been available in Europe, Asia, and Latin America. While the SIA requires FDA to take concrete steps to more quickly review submissions regarding OTC sunscreen ingredients, the SIA does
Monica Welt
Pharmaceutical Take-Back Program Deadlines Are Here
By Warren Lehrenbaum & Monica Welt on
Posted in Health Care Reform & ACA
With under a week remaining for drug producers to comply with the first stages of Washington State’s King County drug take-back and disposal program, industry and regulators alike are watching closely. As one of two first-in-the nation programs requiring drug manufacturers to bear the costs of organizing and implementing a drug take-back and disposal program…